相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
S. H. Park et al.
ANNALS OF ONCOLOGY (2021)
Identification of Patients With Locally Advanced Gastric Cancer Who May Benefit From Adjuvant Chemoradiotherapy After D2 dissection: A Propensity Score Matching Analysis
Shu-Bei Wang et al.
FRONTIERS IN ONCOLOGY (2021)
Chemoradiotherapy or chemotherapy as adjuvant treatment for resected gastric cancer: should we use selection criteria?
Houyem Mansouri et al.
REPORTS OF PRACTICAL ONCOLOGY AND RADIOTHERAPY (2021)
Comparison of Perioperative Chemotherapy versus Postoperative Chemoradiotherapy for Operable Stomach Cancer: A Western Canadian Province Experience
Adnan Zaidi et al.
CURRENT ONCOLOGY (2021)
Comparison of Treatment Modalities for Locally Advanced Gastric Cancer: A Propensity Score Matching Analysis
Jianglong Han et al.
JOURNAL OF CANCER (2020)
Adjuvant radiochemotherapy vs. chemotherapy alone in gastric cancer: ameta-analysis
Christiane Matuschek et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2019)
Benefit of adjuvant chemoradiotherapy in patients with pathological stage III gastric cancer
Gui-Fen Ma et al.
CANCER MANAGEMENT AND RESEARCH (2019)
Current cancer situation in China: good or bad news from the 2018 Global Cancer Statistics?
Rui-Mei Feng et al.
CANCER COMMUNICATIONS (2019)
Chemoradiotherapy versus chemotherapy as adjuvant treatment for localized gastric cancer: a propensity score-matched analysis
Daniel M. Girardi et al.
BMC CANCER (2018)
Adjuvant chemoradiotherapy versus adjuvant chemotherapy for R1 resected gastric cancer: a retrospective cohort study
Meng-Long Zhou et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
Annemieke Cats et al.
LANCET ONCOLOGY (2018)
Necessity of adjuvant concurrent chemo-radiotherapy in D2-resected LN-positive gastric cancer
Jeong Il Yu et al.
RADIOTHERAPY AND ONCOLOGY (2018)
Late gastrointestinal toxicity after radiotherapy for anal cancer: a systematic literature review
Yi Bin Pan et al.
ACTA ONCOLOGICA (2018)
Role of lymph node ratio in selection of adjuvant treatment (chemotherapy vs. chemoradiation) in patients with resected gastric cancer
Brice Jabo et al.
JOURNAL OF GASTROINTESTINAL ONCOLOGY (2018)
The 30-year experienced-A meta-analysis of randomised and high-quality non-randomised studies of hyperthermic intraperitoneal chemotherapy in the treatment of gastric cancer
Jacopo Desiderio et al.
EUROPEAN JOURNAL OF CANCER (2017)
Adjuvant Radiotherapy Improves Overall Survival in Patients With Resected Gastric Adenocarcinoma: A National Cancer Data Base Analysis
Priscilla K. Stumpf et al.
CANCER (2017)
Lymph Node Burden as a Predictive Factor for Selective Chemoradiotherapy in Patients With Locally Advanced Gastric Cancer After a D2 Dissection: A Retrospective Study
Qiwen Li et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2017)
Perioperative Chemotherapy Versus Postoperative Chemoradiotherapy in Patients With Resectable Gastric/Gastroesophageal Junction Adenocarcinomas: A Survival Analysis of 5058 Patients
Timothy L. Fitzgerald et al.
CANCER (2017)
Implications of Lymph Node Staging on Selection of Adjuvant Therapy for Gastric Cancer in the United States A Propensity Score-matched Analysis
Jashodeep Datta et al.
ANNALS OF SURGERY (2016)
Identification of patients with lymph node metastasis from gastric cancer who may benefit from adjuvant chemoradiotherapy after D2 dissection-do N3 patients benefit from additional radiation?
Ming Fan et al.
BRITISH JOURNAL OF RADIOLOGY (2016)
D2-resected stage IIIc gastric cancer patients benefit from adjuvant chemoradiotherapy
Jin Peng et al.
CANCER MEDICINE (2016)
Radiation therapy and neutropenia
Roshan S. Prabhu et al.
CURRENT PROBLEMS IN CANCER (2015)
Adjuvant chemoradiation versus chemotherapy for stage III gastric cancer after surgery with curative intent
Sevim Turanli et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2015)
Phase III Trial to Compare Adjuvant Chemotherapy With Capecitabine and Cisplatin Versus Concurrent Chemoradiotherapy in Gastric Cancer: Final Report of the Adjuvant Chemoradiotherapy in Stomach Tumors Trial, Including Survival and Subset Analyses
Se Hoon Park et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Does Adjuvant Chemoradiotherapy Improve the Prognosis of Gastric Cancer After an R1 Resection? Results from a Dutch Cohort Study
Jurrien Stiekema et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Impact of External-Beam Radiation Therapy on Outcomes Among Patients with Resected Gastric Cancer: A Multi-institutional Analysis
Aslam Ejaz et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Adjuvant chemotherapy for gastric cancer: Current evidence and future challenges
Rosalba Miceli et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Gastric cancer epidemiology and risk factors
Douglas E. Guggenheim et al.
JOURNAL OF SURGICAL ONCOLOGY (2013)
Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival
Hamid Reza Raziee et al.
GASTRIC CANCER (2012)
Phase 3 Trial of Postoperative Chemotherapy Alone Versus Chemoradiation Therapy in Stage III-IV Gastric Cancer Treated With R0 Gastrectomy and D2 Lymph Node Dissection
Tae Hyun Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Intensity-modulated radiotherapy combined with chemotherapy for the treatment of gastric cancer patients after standard D1/D2 surgery
Changhua Yu et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2012)
Phase III Trial Comparing Capecitabine Plus Cisplatin Versus Capecitabine Plus Cisplatin With Concurrent Capecitabine Radiotherapy in Completely Resected Gastric Cancer With D2 Lymph Node Dissection: The ARTIST Trial
Jeeyun Lee et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2012)
A randomized, controlled, multicenter study comparing intensity-modulated radiotherapy plus concurrent chemotherapy with chemotherapy alone in gastric cancer patients with D2 resection
Wei-guo Zhu et al.
RADIOTHERAPY AND ONCOLOGY (2012)
Meta-Analysis of D1 Versus D2 Gastrectomy for Gastric Adenocarcinoma
Muhammed Ashraf Memon et al.
ANNALS OF SURGERY (2011)
Perioperative Chemotherapy Compared With Surgery Alone for Resectable Gastroesophageal Adenocarcinoma: An FNCLCC and FFCD Multicenter Phase III Trial
Marc Ychou et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Adjuvant chemoradiation versus chemotherapy in completely resected advanced gastric cancer with D2 nodal dissection
Hyuk-Chan Kwon et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2010)
A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer
Aristotelis Bamias et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Neoadjuvant Chemotherapy Compared With Surgery Alone for Locally Advanced Cancer of the Stomach and Cardia: European Organisation for Research and Treatment of Cancer Randomized Trial 40954
Christoph Schuhmacher et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial
Ilfet Songun et al.
LANCET ONCOLOGY (2010)
Clinical Impact of Positive Surgical Margin Status on Gastric Cancer Patients Undergoing Gastrectomy
Shang-Yu Wang et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer
David Cunningham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Survival after gastric adenocarcinoma resection: Eighteen-year experience at a single institution
SC Cunningham et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2005)
Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer
DJ Adelstein et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
JS Macdonald et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
分享论文
